Bsa I (RNase-free): Practical DNA Cleavage Guide

Bsa I (RNase-free), SKU K1095, is a recombinant mutant protein expressed in Escherichia coli and derived from the BsaI gene of Bacillus stearothermophilus. It is a type IIS restriction endonuclease that recognizes the sequence 5'—GGTCTC(N)—3' and cleaves at a defined position downstream of that recognition sequence. This arrangement makes the enzyme useful when a DNA construct must be cut at a site separated from the recognition sequence rather than directly within it.

The product is supplied with 10X Cut rA Buffer and is available in 1000 U, 5000 U, and 10000 U sizes. Product information from Bsa I (RNase-free) should be checked alongside the current lot instructions before establishing reaction volume, incubation conditions, and enzyme input. The guidance below is dossier-based and supplemented with general laboratory workflow practices; it does not represent a directly matched paper performance study.

For related parameter discussion, see Bsa I (RNase-free): Technical Parameters for DNA Manipulation, which provides complementary context for sequence-directed DNA cleavage. For cloning-focused workflow considerations, see Bsa I (RNase-free): Technical Guidance for DNA Cloning Workflows, which addresses the same enzyme in gene cloning and recombinant DNA applications.

What This Product Solves

The primary problem addressed by Bsa I is controlled cleavage of DNA substrates that contain the specified recognition sequence. Because cleavage occurs downstream of the recognition sequence, researchers can use the enzyme in designed DNA assembly, plasmid construction, and other gene cloning workflows where the cut position must be considered during construct planning. The exact product dossier supports recognition of 5'—GGTCTC(N)—3' and downstream cleavage, but it does not specify the complete overhang geometry in the supplied information. Do not infer overhang length or ligation compatibility without confirming the construct map and current technical instructions.

The RNase-free formulation is relevant when DNA manipulation is performed alongside RNA-sensitive steps or when RNA contamination could compromise a downstream assay. It does not make an entire procedure RNase-free by itself. Water, tubes, pipette tips, work surfaces, reagents, and operator technique must also be controlled. In molecular biology research, the product is therefore best viewed as one component of a clean nucleic acid workflow rather than as a substitute for general contamination control.

Protocol Parameters

• Assay: Sequence-directed DNA cleavage; value: 5'—GGTCTC(N)—3' recognition sequence; applicability: DNA substrates whose verified sequence contains the Bsa I site in the intended construct orientation and context; rationale: the recognition sequence determines whether the enzyme can engage the substrate, while the type IIS design places cleavage downstream; product basis: product dossier.
• Assay: Reaction buffer; value: supplied 10X Cut rA Buffer; applicability: Bsa I digestion setup using the accompanying product formulation; rationale: the supplied concentrated buffer is intended to provide the reaction environment specified for the enzyme; product basis: product dossier. Use the current instructions to calculate its final concentration rather than substituting an unvalidated buffer.
• Assay: Enzyme supply options; value: 1000 U, 5000 U, or 10000 U; applicability: experiment planning, screening, and larger cloning programs; rationale: package size affects inventory planning but does not by itself define the amount required for an individual digest; product basis: product dossier.
• Assay: Storage; value: −80 °C; applicability: unopened and in-use reagent storage according to the product instructions; rationale: the dossier identifies this temperature as necessary to maintain stability and activity; product basis: product dossier. Minimize unnecessary warming and repeated freeze-thaw exposure.
• Assay: Reaction time, temperature, volume, and enzyme input; value: use the current lot-specific instructions or a validated optimization matrix; applicability: initial method development and any substrate or buffer change; rationale: these operating values are not provided in the dossier and should not be invented or transferred from another restriction enzyme; workflow recommendation: confirm experimentally with appropriate controls.

Workflow Setup and QC Checklist

1. Verify the DNA design

Inspect the plasmid map or assembled sequence before opening the reagent. Confirm every intended Bsa I recognition site, its flanking bases, and the downstream cut position used in the design. Check for unwanted internal sites in the backbone, insert, donor fragment, or assembled product. Sequence verification is preferable when a single base change could remove the site or alter the intended construct.

2. Prepare an RNase-controlled workspace

Use nuclease-free water, certified RNase-free tubes and tips, clean gloves, and a workspace separated from RNA-degrading reagents. Keep DNA and enzyme preparations closed except during setup. Thaw the enzyme and supplied buffer according to the current instructions, keep them cold during assembly, mix gently rather than vortexing, and briefly collect liquid at the bottom of the tube if needed. Return the enzyme to −80 °C promptly after use.

3. Assemble the digest consistently

Use the supplied 10X Cut rA Buffer and calculate all additions from the final reaction volume specified by the validated method. Add water and buffer first, then DNA, and add Bsa I last to reduce the time the concentrated enzyme spends in the assembled mixture before the reaction begins. Avoid carrying excess EDTA, salts, ethanol, detergents, or chaotropic agents from DNA purification into the digest. When using a new substrate, perform a small-scale test before committing the full sample.

4. Include controls and inspect the product

At minimum, include an uncut DNA control and a no-enzyme control when troubleshooting. A known digestible DNA control can help distinguish enzyme or buffer problems from substrate-specific issues. Resolve the products using an analytical method appropriate for the fragment sizes and DNA form. Compare the observed pattern with a map-based prediction; do not interpret a band shift as successful cleavage unless the expected fragment arrangement is clear.

5. Protect downstream RNA-sensitive steps

If RNA is present in the broader workflow, treat all subsequent reagents and handling steps as potential RNase sources. The RNase-free enzyme formulation can reduce the risk associated with the enzyme preparation, but it cannot validate RNA integrity under every buffer, temperature, or incubation condition. Include an RNA integrity control when RNA quality is a critical release criterion.

Common Failure Modes and Fixes

No detectable cleavage

First confirm that the recognition sequence is present and has not been removed by synthesis, PCR, mutation, or recombination. Recheck the DNA map and the intended downstream cleavage position. Then verify that the supplied buffer was used correctly, the enzyme was stored at −80 °C, and the substrate does not contain carryover inhibitors. A digestible control can identify whether the problem is reagent-related. If the control works but the sample does not, redesign or resequence the target region before increasing enzyme input.

Partial digestion

Partial cleavage can result from insufficiently accessible substrate, inhibitory contaminants, incorrect reaction composition, or conditions that do not match the product instructions. Purify the DNA more thoroughly, reduce contaminant carryover, confirm mixing, and test a controlled range of enzyme input or reaction duration as a workflow optimization. Do not compensate indefinitely by adding more enzyme; first establish whether the recognition sites and reaction environment are correct.

Unexpected fragment pattern

Unexpected bands may reflect an unrecognized internal site, an incorrect plasmid map, mixed DNA populations, incomplete digestion, or an incorrect assumption about the downstream cut location. Reinspect the full sequence rather than only the intended cloning junction. If non-specific cleavage is suspected, return to the recommended reaction conditions and avoid unnecessarily prolonged or excessive digestion until the cause is identified.

RNA degradation despite the RNase-free formulation

Check water, tips, tubes, buffers, and shared work surfaces for RNase exposure. Separate RNA handling from routine DNA work and use fresh contamination-controlled reagents. The label describes the enzyme preparation as RNase-free and suitable for sensitive nucleic acid manipulation, but it does not guarantee protection against RNases introduced elsewhere in the workflow.

Scope and Limitations

This article is intended for research use planning around Bsa I-mediated DNA cleavage. The available dossier establishes the recombinant origin, type IIS classification, recognition sequence, supplied buffer, package sizes, storage temperature, and RNase-free positioning. It does not provide a complete reaction recipe, a universal incubation temperature, a digestion time, a unit-to-DNA ratio, a guaranteed overhang specification, or performance data for every substrate. Those values must come from the current product instructions or be established in the user's own validation work.

Bsa I (RNase-free) is not a diagnostic reagent and is not intended for medical or clinical use. Compatibility with a particular ligase, amplification mixture, RNA preparation, or high-throughput automation method should be demonstrated rather than assumed. The product also cannot correct errors in construct design, contaminated reagents, damaged DNA, or inaccurate sequence maps.

Conclusion

Bsa I (RNase-free) is a practical molecular cloning enzyme for DNA substrates containing the 5'—GGTCTC(N)—3' recognition sequence and a designed downstream cleavage site. Reliable use depends on sequence verification, correct use of the supplied 10X Cut rA Buffer, controlled storage at −80 °C, RNase-aware handling, and digest controls. Where the dossier does not specify a numerical reaction condition, use the current instructions or perform a documented optimization instead of relying on assumptions from unrelated restriction enzymes.